Article

Challenges of treating peripheral hemorrhagic polypoidal choroidal vasculopathy

Author(s):

Lynda Charters
Conferences|EURETINA

A case study details the care of a patient who had already lost vision in one eye from a similar issue.

Related Videos
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Vikas Chopra, MD, at AAO 2024: The role of MIGS in earlier intervention and safer techniques
Related Content
Beacon Therapeutics announces positive 3-month data from Phase 2 DAWN trial of AGTC-501 in patients with X-linked retinitis pigmentosa
December 10th 2024

Beacon Therapeutics announces positive 3-month data from Phase 2 DAWN trial of AGTC-501 in patients with X-linked retinitis pigmentosa

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Study: CRVO patients face higher heart attack risk
December 7th 2024

Study: CRVO patients face higher heart attack risk

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology
November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

EyePoint doses first patient in second global Phase 3 LUCIA clinical trial of Duravyu for the treatment of wet AMD
December 4th 2024

EyePoint doses first patient in second global Phase 3 LUCIA clinical trial of Duravyu for the treatment of wet AMD

Prevent Blindness providing free educational resources on geographic atrophy
December 1st 2024

Prevent Blindness providing free educational resources on geographic atrophy

© 2024 MJH Life Sciences

All rights reserved.